Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?

Oncology remains the major focus area in R&D for large pharma companies as global spending in the area continues to grow. Immunotherapies, in particular, have quickly become some of the best-selling products on the market. Seeking ever more efficacious treatments, companies are now eyeing cancer vaccines, which experts say could be more powerful than other immunotherapies and may even provide a preventative measure against certain malignancies.